Debra Zack
No más puestos en curso
Fortuna: 246 418 $ al 29/02/2024
Perfil
Debra Jeske Zack is former Chief Medical Officer of Exagen, Inc., former Executive Director-Global Product Area at Amgen, Inc., former Vice President-Clinical Development at Xencor, Inc. and former Associate Professor at the University of California, Los Angeles.
She received an undergraduate degree from Texas Christian University and a doctorate from The University of Texas Southwestern Medical Center.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
EXAGEN, INC.
0.64% | 18/04/2023 | 109 519 ( 0.64% ) | 246 418 $ | 29/02/2024 |
Antiguos cargos conocidos de Debra Zack.
Empresas | Cargo | Fin |
---|---|---|
EXAGEN INC. | Chief Tech/Sci/R&D Officer | 05/12/2022 |
University of California, Los Angeles | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
XENCOR, INC. | Corporate Officer/Principal | - |
Formación de Debra Zack.
Texas Christian University | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
AMGEN INC. | Health Technology |
XENCOR, INC. | Health Technology |
EXAGEN INC. | Health Services |